Search results
Bristol-Myers Squibb Company (BMY) Impacted by Delay in New Product Launches
Insider Monkey via Yahoo Finance· 1 month agoAriel Investments, an investment management company, released its “Ariel Global Fund” fourth-quarter...
Bristol Myers Squibb acquires Karuna Therapeutics for $14 billion, boosting neuroscience portfolio
Associated Press via AOL· 5 months agoDrugmaker Bristol Myers Squibb is acquiring Karuna Therapeutics, a biopharmaceutical company that...
Bristol-Myers Squibb to acquire Mirati in up to $5.8 billion deal
Reuters via Yahoo News· 7 months ago(Reuters) -Bristol-Myers Squibb on Sunday said it will acquire cancer drugmaker Mirati Therapeutics...
Will Bristol Myers (BMY) Gain From New Drugs' Label Expansion?
Zacks via Yahoo Finance· 1 year agoBristol-Myers Squibb BMY has recently been enjoying a string of positive regulatory updates. The...
Bristol-Myers (BMY) Q3 Earnings Beat, Sales Decline Y/Y
Zacks via Yahoo Finance· 2 years agoBristol-Myers Squibb Company BMY reported decent results for the third quarter of 2022. The company...
Here’s Why Aristotle Atlantic Core Equity Strategy Sold Bristol-Myers Squibb Company (BMY)
Insider Monkey via Yahoo Finance· 2 months agoAristotle Atlantic Partners, LLC, an investment management company, released its “Core Equity...
Will New Drugs Help Bristol Myers (BMY) Combat Generic Pressure?
Zacks via Yahoo Finance· 2 years agoBiotech bigwig Bristol Myers BMY has had a decent run this year despite one of its top drugs...
Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 1 year agoFor new and old investors, taking full advantage of the stock market and investing with confidence...
Bristol Myers accused of illegal tactics to keep Pomalyst monopoly in lawsuit
Reuters via AOL· 8 months agoBristol Myers Squibb has been accused in a new lawsuit of using fraudulent patents and other illegal...
Bristol Myers CEO sees mid-decade transition, late decade growth
Reuters via Yahoo Finance· 3 months ago(Reuters) -Bristol Myers Squibb's new chief executive said on Friday that the company was focused on...